Dimethyl fumarate Accord Evropska unija - slovenščina - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Polpharma Evropska unija - slovenščina - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil fumarat - multiplo sklerozo, recidivno-nakazila - imunosupresivi - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Evropska unija - slovenščina - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil fumarat - multiplo sklerozo, recidivno-nakazila - imunosupresivi - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Evropska unija - slovenščina - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Neuraxpharm Evropska unija - slovenščina - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil fumarat - multiplo sklerozo, recidivno-nakazila - imunosupresivi - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Tecfidera Evropska unija - slovenščina - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetil fumarat - multiple skleroza - imunosupresivi - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Skilarence Evropska unija - slovenščina - EMA (European Medicines Agency)

skilarence

almirall s.a - dimetil fumarat - psoriaza - imunosupresivi - skilarence je indicirano za zdravljenje zmerne do hude psoriaze v odrasli potrebujejo sistemska zdravila zdravljenje.